154 related articles for article (PubMed ID: 32598563)
1. Ethnic differences in association of outcomes with trimethylamine N-oxide in acute heart failure patients.
Yazaki Y; Aizawa K; Israr MZ; Negishi K; Salzano A; Saitoh Y; Kimura N; Kono K; Heaney L; Cassambai S; Bernieh D; Lai F; Imai Y; Kario K; Nagai R; Ng LL; Suzuki T
ESC Heart Fail; 2020 Oct; 7(5):2373-2378. PubMed ID: 32598563
[TBL] [Abstract][Full Text] [Related]
2. Association of gut-related metabolites with outcome in acute heart failure.
Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Heaney LM; Jones DJL; Ng LL; Suzuki T
Am Heart J; 2021 Apr; 234():71-80. PubMed ID: 33454370
[TBL] [Abstract][Full Text] [Related]
3. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
4. Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF.
Suzuki T; Yazaki Y; Voors AA; Jones DJL; Chan DCS; Anker SD; Cleland JG; Dickstein K; Filippatos G; Hillege HL; Lang CC; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; Metra M; Ng LL
Eur J Heart Fail; 2019 Jul; 21(7):877-886. PubMed ID: 30370976
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
[TBL] [Abstract][Full Text] [Related]
6. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure.
Anderson KM; Ferranti EP; Alagha EC; Mykityshyn E; French CE; Reilly CM
Heart Fail Rev; 2022 Nov; 27(6):2223-2249. PubMed ID: 35726110
[TBL] [Abstract][Full Text] [Related]
7. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
8. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
9. Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis.
Wang M; Li XS; Wang Z; de Oliveira Otto MC; Lemaitre RN; Fretts A; Sotoodehnia N; Budoff M; Nemet I; DiDonato JA; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
Eur Heart J; 2023 May; 44(18):1608-1618. PubMed ID: 36883587
[TBL] [Abstract][Full Text] [Related]
10. Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure.
Li N; Zhou J; Wang Y; Chen R; Li J; Zhao X; Zhou P; Liu C; Song L; Liao Z; Wang X; Yan S; Zhao H; Yan H
ESC Heart Fail; 2022 Dec; 9(6):3846-3857. PubMed ID: 35686339
[TBL] [Abstract][Full Text] [Related]
11. Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis.
Yuzefpolskaya M; Bohn B; Javaid A; Mondellini GM; Braghieri L; Pinsino A; Onat D; Cagliostro B; Kim A; Takeda K; Naka Y; Farr M; Sayer GT; Uriel N; Nandakumar R; Mohan S; Colombo PC; Demmer RT
Circ Heart Fail; 2021 Jun; 14(6):e007909. PubMed ID: 34129361
[TBL] [Abstract][Full Text] [Related]
12. All-Cause Mortality and Trimethylamine N-Oxide Levels in Patients with Cardiovascular Disease.
Konieczny R; Żurawska-Płaksej E; Kaaz K; Czapor-Irzabek H; Bombała W; Mysiak A; Kuliczkowski W
Cardiology; 2022; 147(4):443-452. PubMed ID: 35970148
[TBL] [Abstract][Full Text] [Related]
13. The correlation between plasma trimethylamine N-oxide level and heart failure classification in northern Chinese patients.
Dong Z; Liang Z; Wang X; Liu W; Zhao L; Wang S; Hai X; Yu K
Ann Palliat Med; 2020 Sep; 9(5):2862-2871. PubMed ID: 32921087
[TBL] [Abstract][Full Text] [Related]
14. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
16. Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction.
Kinugasa Y; Nakamura K; Kamitani H; Hirai M; Yanagihara K; Kato M; Yamamoto K
ESC Heart Fail; 2021 Jun; 8(3):2103-2110. PubMed ID: 33734604
[TBL] [Abstract][Full Text] [Related]
17. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Heart Fail Clin; 2020 Jan; 16(1):23-31. PubMed ID: 31735312
[TBL] [Abstract][Full Text] [Related]
18. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction.
Zhou X; Jin M; Liu L; Yu Z; Lu X; Zhang H
ESC Heart Fail; 2020 Feb; 7(1):188-193. PubMed ID: 31960610
[TBL] [Abstract][Full Text] [Related]
19. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Cardiol Clin; 2022 May; 40(2):161-169. PubMed ID: 35465890
[TBL] [Abstract][Full Text] [Related]
20. Trimethylamine-N-oxide (TMAO) predicts short- and long-term mortality and poor neurological outcome in out-of-hospital cardiac arrest patients.
Hochstrasser SR; Metzger K; Vincent AM; Becker C; Keller AKJ; Beck K; Perrig S; Tisljar K; Sutter R; Schuetz P; Bernasconi L; Neyer P; Marsch S; Hunziker S
Clin Chem Lab Med; 2020 Aug; 59(2):393-402. PubMed ID: 32866111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]